Outset Medical saw the highest growth of 0.49% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.49% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of Outset Medical’s patent filings and grants. Buy the databook here.
Outset Medical has been focused on protecting inventions in Australia(AU) with one publication in Q2 2024
The Australia(AU) Patent Office dominates the patent filings with nearly 100% of filings. The Australia(AU), and United States(US) patent Office are among the top ten patent offices where Outset Medical is filings its patents. Among the top granted patent authorities, Outset Medical has 100% of its grants in United States(US).
Fresenius Medical Care could be the strongest competitor for Outset Medical
In terms of grant share, Outset Medical stands in sixth position among its competitors. Outset Medical and Fresenius Medical Care secured the top positions according to recent patent publication data.
Patents related to water management lead Outset Medical's portfolio
Outset Medical has the highest number of patents in water management. For water management no patents were filed and 100% of patents were granted in Q2 2024.
Nephrology and urology devices related patents lead Outset Medical portfolio followed by drug delivery devices
Outset Medical has highest number of patents in nephrology and urology devices followed by drug delivery devices. For nephrology and urology devices, nearly 100% of patents were filed and 50% of patents were granted in Q2 2024.
For comprehensive analysis of Outset Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.